Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Seminars in Neurology|November 21, 2023
Leptomeningeal Carcinomatosis from Solid Tumor Malignancies: Treatment Strategies and BiomarkersRachna Malani, Ankush Bhatia, Allison Betof Warner, et al.
Frontiers in Immunology|January 28, 2022
Factors Determining Long-Term Antitumor Responses to Immune Checkpoint Blockade Therapy in MelanomaKimberly Loo, James W Smithy, Michael A Postow, et al.
Seminars in Radiation Oncology|December 22, 2018
Exercise as Adjunct Therapy in CancerKathleen A Ashcraft, Allison Betof Warner, Lee W Jones, et al.
Cancer Research|May 10, 2019
Can Exercise-Induced Modulation of the Tumor Physiologic Microenvironment Improve Antitumor Immunity?Xiaojie Zhang, Kathleen A Ashcraft, Allison Betof Warner, et al.
Melanoma Research|December 22, 2022
Real-world outcomes of different lines and sequences of treatment in BRAF-positive advanced melanoma patientsAllison Betof Warner, Ahmad Tarhini, Barinder Kang, et al.
Pharmacoepidemiology and Drug Safety|April 24, 2023
Real-world treatment patterns and outcomes for patients with advanced melanoma treated with immunotherapy or targeted therapySejin Lee, Antonia V Bennett, Xi Zhou, et al.
Journal for Immunotherapy of Cancer|October 27, 2021
Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumabPaul B Chapman, Vetri Sudar Jayaprakasam, Katherine S Panageas, et al.
The Journal of Experimental Medicine|September 21, 2019
Selective inhibition of low-affinity memory CD8+ T cells by corticosteroidsAkihiro Tokunaga, Daisuke Sugiyama, Yuka Maeda, et al.
Journal of the National Cancer Institute. Monographs|August 19, 2025
The multidisciplinary community of exercise oncology practice: current status and future directionsChao Cao, Kristin L Campbell, Allison Betof Warner, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|April 10, 2010
A phase I/II study of neoadjuvant liposomal doxorubicin, paclitaxel, and hyperthermia in locally advanced breast cancerZeljko Vujaskovic, Dong W Kim, Ellen Jones, et al.
Pageof 6